Insights

Clinical-stage oncology ZielBio is a clinical-stage biotechnology company developing cancer therapeutics, signaling potential for partnerships in early-stage drug development, co-development, or licensing opportunities with larger biopharma seeking innovative oncology targets.

Target discovery platform The company emphasizes identifying druggable and specific targets that could change disease treatment, presenting a sellable value proposition for collaboration on target validation, biomarker-driven programs, or platform-as-a-service engagements.

Strategic leadership Appointment of a new CEO with board credentials indicates leadership maturation and investor confidence, suggesting opportunities for advisor, collaboration, or strategic funding conversations with growth-oriented partners.

Funding traction With prior Series A funding and total funding of $33M and revenue under $1M, ZielBio may be open to co-funding, strategic investments, or grant-assisted partnerships to accelerate clinical development and expand its oncology pipeline.

Global tech stack Utilizes mainstream cloud, analytics, and CMS tools (Google Cloud, WordPress, Google Analytics, etc.), indicating readiness for scalable partnerships, data-sharing arrangements, and digital collaboration platforms to support joint research programs.

Similar companies to ZielBio, Inc.

ZielBio, Inc. Tech Stack

ZielBio, Inc. uses 8 technology products and services including WordPress, Shopify, Microsoft 365, and more. Explore ZielBio, Inc.'s tech stack below.

ZielBio, Inc.'s Email Address Formats

ZielBio, Inc. uses at least 1 email format:
ZielBio, Inc. Email FormatsExamplePercentage
FLast@zielbio.comJDoe@zielbio.com
100%

Frequently Asked Questions

What is ZielBio, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
ZielBio, Inc.'s official website is zielbio.com and has social profiles on LinkedIn.

How much revenue does ZielBio, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, ZielBio, Inc.'s annual revenue is estimated to be <$1M.

What is ZielBio, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
ZielBio, Inc.'s SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ZielBio, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, ZielBio, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include Chief Executive Officer: G. K. Explore ZielBio, Inc.'s employee directory with LeadIQ.

What industry does ZielBio, Inc. belong to?

Minus sign iconPlus sign icon
ZielBio, Inc. operates in the Biotechnology industry.

What technology does ZielBio, Inc. use?

Minus sign iconPlus sign icon
ZielBio, Inc.'s tech stack includes WordPress, Shopify, Microsoft 365, Google Cloud, WP Engine, Yoast SEO, Google Analytics and Nginx.

What is ZielBio, Inc.'s email format?

Minus sign iconPlus sign icon
ZielBio, Inc.'s email format typically follows the pattern of FLast@zielbio.com. Find more ZielBio, Inc. email formats with LeadIQ.

How much funding has ZielBio, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, ZielBio, Inc. has raised $33M in funding. The last funding round occurred on Sep 27, 2022.

When was ZielBio, Inc. founded?

Minus sign iconPlus sign icon
ZielBio, Inc. was founded in 2010.
ZielBio, Inc. logo

ZielBio, Inc.

BiotechnologyVirginia, United States0-1 Employees

ZielBio, Inc. is a clinical-stage biotechnology company focused on discovering and developing targeted cancer therapies. It employs a technology platform to identify disease-relevant, druggable targets with the potential to improve how cancer is treated. The company is advancing several therapeutic candidates to broaden treatment options for patients with cancer.

Based in Charlottesville, Virginia, ZielBio belongs to the biotechnology research sector and positions itself as a developer of oncology therapeutics. As a small to mid-sized organization, it engages with the clinical community and patients to pursue more precise and effective cancer care. In early 2023, the company appointed Alan Bash as chief executive officer and board member, signaling leadership evolution as it progresses its oncology programs.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
0-1

Section iconFunding & Financials

  • $33M

    ZielBio, Inc. has raised a total of $33M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2022 as a Venture Round.

  • <$1M

    ZielBio, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.